[{"NetIncomeLoss_1_Q2_USD":-15203000.0,"DefinedBenefitPlanExpectedReturnOnPlanAssets_3_Q2_USD":93000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q2_USD":-166271000.0,"DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_0_Q2_USD":26200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-9748000.0,"InterestPaidNet_3_Q2_USD":119000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":14689000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":334315000.0,"PaymentsToAcquireLongtermInvestments_3_Q2_USD":95468000.0,"DefinedBenefitPlanExpectedReturnOnPlanAssets_1_Q2_USD":32000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":21536000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-77000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q2_USD":48000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q2_USD":-100000.0,"DefinedContributionPlanCostRecognized_1_Q2_USD":3500000.0,"DefinedContributionPlanCostRecognized_3_Q2_USD":10100000.0,"ConstructionPayableCurrent_0_Q2_USD":12835000.0,"Liabilities_0_Q2_USD":916597000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":92149000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q2_USD":5085000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":2532000.0,"AssetsCurrent_0_Q2_USD":2159425000.0,"DefinedBenefitPlanInterestCost_3_Q2_USD":142000.0,"ShareBasedCompensation_3_Q2_USD":132616000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_3_Q2_USD":1500000.0,"Assets_0_Q2_USD":3307430000.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":131000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":9745000.0,"CommonStockSharesIssued_0_Q2_shares":218903097.0,"DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_0_Q2_USD":4000000.0,"IncomeTaxesPaidNet_3_Q2_USD":56757000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":7783000.0,"FinanceLeaseInterestExpense_1_Q2_USD":300000.0,"FinanceLeaseInterestExpense_3_Q2_USD":900000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":15678728.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q2_shares":15678728.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_0_Q2_USD":87.45,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":32848000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":120788000.0,"SellingGeneralAndAdministrativeExpense_3_Q2_USD":349934000.0,"OtherNoncashIncomeExpense_3_Q2_USD":-8698000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":4276667000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":13424000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1497775000.0,"OtherAssetsNoncurrent_0_Q2_USD":53109000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":6873000.0,"Revenues_1_Q2_USD":620643000.0,"Revenues_3_Q2_USD":1877193000.0,"CommonStockValue_0_Q2_USD":219000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":11695000.0,"IncomeTaxExpenseBenefit_3_Q2_USD":45227000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":4917000.0,"OtherNonoperatingIncomeExpense_3_Q2_USD":18396000.0,"ProceedsFromStockPlans_3_Q2_USD":91596000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q2_USD":62196000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":218784000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q2_shares":217684000.0,"FinanceLeasePrincipalPayments_3_Q2_USD":619000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":-13207000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q2_USD":10935000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q2_USD":5085000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":21536000.0,"EarningsPerShareBasic_1_Q2_USD":-0.07,"EarningsPerShareBasic_3_Q2_USD":-2.05,"GoodwillPeriodIncreaseDecrease_3_Q2_USD":0.0,"DefinedBenefitPlanInterestCost_1_Q2_USD":49000.0,"DefinedBenefitPlanNetPeriodicBenefitCost_3_Q2_USD":5167000.0,"RestrictedCashAndInvestmentsNoncurrent_0_Q2_USD":2663000.0,"IncreaseDecreaseInAccountsPayable_3_Q2_USD":38865000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-12528000.0,"ComprehensiveIncomeNetOfTax_3_Q2_USD":-439753000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-15203000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q2_USD":-445547000.0,"IncreaseDecreaseInInventories_3_Q2_USD":9204000.0,"ProvisionForLossOnContracts_0_Q2_USD":73610000.0,"DefinedBenefitPlanActuarialGainLoss_1_Q2_USD":-166000.0,"DefinedBenefitPlanActuarialGainLoss_3_Q2_USD":-500000.0,"ConvertibleDebtCurrent_0_Q2_USD":11900000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q2_USD":466591000.0,"CostsAndExpenses_1_Q2_USD":615317000.0,"CostsAndExpenses_3_Q2_USD":2305098000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":7109000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q2_USD":19790000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q2_USD":59837000.0,"StockIssuedDuringPeriodSharesIssuedForServices_1_Q2_shares":1434.0,"DepreciationDepletionAndAmortization_3_Q2_USD":38641000.0,"InterestPayableCurrent_0_Q2_USD":56000.0,"DefinedBenefitPlanNetPeriodicBenefitCost_1_Q2_USD":1760000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"DebtConversionConvertedInstrumentAmount1_3_Q2_USD":6992000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LiabilitiesCurrent_0_Q2_USD":606202000.0,"CostOfRevenue_1_Q2_USD":34322000.0,"CostOfRevenue_3_Q2_USD":95005000.0,"PaymentsToAcquireProductiveAssets_3_Q2_USD":135946000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":39050000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":218784000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q2_shares":217684000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1275000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q2_USD":-231920000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":43970000.0,"Goodwill_0_Q2_USD":155593000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.036,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":2675000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q2_USD":5794000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":137148000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":21536000.0,"ProceedsFromSaleOfLongtermInvestments_3_Q2_USD":17250000.0,"PaymentsToAcquireMarketableSecurities_3_Q2_USD":418698000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":21536000.0,"AccountsPayableCurrent_0_Q2_USD":122512000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.07,"StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1_Q2_shares":134413.0,"InterestExpense_1_Q2_USD":544000.0,"NetIncomeLoss_3_Q2_USD":-445547000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":498335000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":232950000.0,"InventoryNoncurrent_0_Q2_USD":8697000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q2_USD":12836000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":86147000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_3_Q2_USD":8700000.0,"NumberOfOperatingSegments_3_Q2_segment":1.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0_Q2_shares":3167196.0,"OtherIntangibleAssetsNet_0_Q2_USD":177675000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-15203000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q2_USD":-445547000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.045,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":700000.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q2_USD":1900000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_1_Q2_shares":698032.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":51431000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1500438000.0,"InterestExpense_3_Q2_USD":1746000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":438109000.0,"EarningsPerShareDiluted_3_Q2_USD":-2.05,"IncreaseDecreaseInAccountsReceivable_3_Q2_USD":55656000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":3307430000.0,"OperatingLeaseCost_1_Q2_USD":2900000.0,"OperatingLeaseCost_3_Q2_USD":9000000.0,"PreferredStockValue_0_Q2_USD":null,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":-220000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3_Q2_USD":-661000.0,"InventoryNet_0_Q2_USD":17012000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":237025000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":236902000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-3508000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q2_USD":-400320000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":5767844.0,"OperatingIncomeLoss_1_Q2_USD":5326000.0,"OperatingIncomeLoss_3_Q2_USD":-427905000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":620643000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q2_USD":1877193000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q2_USD":11384000.0,"AccountsReceivableNet_0_Q2_USD":356182000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":96391000.0,"CommonStockSharesOutstanding_0_Q2_shares":218903097.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":43800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q2_USD":-333269000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1876305000.0,"DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1_Q2_USD":54000.0,"DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_3_Q2_USD":161000.0,"LongTermInvestments_0_Q2_USD":222810000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":2390833000.0,"OtherLiabilitiesCurrent_0_Q2_USD":49557000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":1978000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":44597000.0,"ProfitLoss_3_Q2_USD":-445547000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q2_USD":13020000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q2_USD":2160000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":5384000.0,"DefinedBenefitPlanServiceCost_1_Q2_USD":1523000.0,"DefinedBenefitPlanServiceCost_3_Q2_USD":4457000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":10713000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":635483000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":29123000.0,"AllocatedShareBasedCompensationExpense_3_Q2_USD":132600000.0,"ResearchAndDevelopmentExpense_3_Q2_USD":1809997000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20201105"}]